$3.04
-0.04-1.30%
Last update: 9:27 AM
15 minutes delayed
Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.60 | $-1.05 | 42.9 % |
Dec 2023 | 2024-03-28 | $-3.05 | $-1.90 | -60.5 % |
Jun 2023 | 2023-08-16 | $-4.50 | $-3.50 | -28.6 % |
Mar 2023 | 2023-06-08 | $-5.00 | $-4.50 | -11.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $4.05M | $3.60M | 12.6 % |
Dec 2023 | 2024-03-28 | $3.25M | $3.41M | -4.75 % |
Jun 2023 | 2023-08-16 | $3.40M | $4.15M | -18.2 % |
Mar 2023 | 2023-06-08 | $3.86M | $4.01M | -3.82 % |
Vivos Therapeutics (VVOS) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.60, which beat the estimate of $-1.05.
The Actual Revenue was $4.1M, which beat the estimate of $3.6M.
Browse earnings estimates, EPS, and revenue on all stocks.